You are here: Welcome » BioVeda China Fund

BioVeda China Fund

BioVeda China Fund (BVCF) is a Chinese investment firm based in Beijing, China.

History

Founding

BVCF was founded by Zhi Yang in 2005 as China's first US dollar-based fund focused on life sciences and healthcare.1)

COVID-19

In July 2019, BVCF participated in BioNTech's $325 million Series B investment round.2) 3)

Organization

Portfolio

1)
Yang, Z. About. BioVeda China Fund (BVCF). Retrieved May 24, 2022, from https://web.archive.org/web/20220524221558/https://bvcf.com/about.asp?nav=2
2)
BioNTech - Funding, Financials, Valuation & Investors. Crunchbase. Retrieved December 28, 2022, from https://www.crunchbase.com/organization/biontech-ag/company_financials/investors
3)
Boehler, M., Schweitzer, G., & May, S. (2019, July 9). BioNTech Raises USD 325 Million in an Upsized Series B Financing to Further Advance Individualized Immuno-Oncology Pipeline. BioNTech. https://web.archive.org/web/20221229025707/https://investors.biontech.de/news-releases/news-release-details/biontech-raises-usd-325-million-upsized-series-b-financing/
4)
Portfolio. BioVeda China Fund (BVCF). Retrieved December 29, 2022, from https://archive.vn/986xR
Back to top